News & Opinionn

 

FDA Says Certain Type 2 Diabetes Drugs Can Cause Serious Joint Pain

 

By Alanna McCatty

August 31, 2015

The U.S. Food and Drug Administration (FDA) said in a safety alert that some widely used treatments for Type 2 diabetes can cause severe and disabling joint pain, raising concerns for a big-selling class of drugs. The FDA alert applies to a category of pills known as DPP-IV inhibitors, which include AstraZeneca PLC’s diabetes drug Onglyza, and Tradjenta. Via The Wall Street Journal. Posted August 28, 2015.

–Alanna McCatty

Alanna McCatty

Alanna McCatty

Alanna McCatty is a recent graduate of Pace University with a degree in communications. At MedShadow, she reports on new findings and research on the side effects of prescription drugs.

JOIN MEDSHADOW IN DEMANDING MARIJUANA RESEARCH

We need scientists to research marijuana - but they can't because the DEA calls it a Schedule I drug. Join us in asking the DEA to name it a Schedule II drug so research can begin. Sign the petition | Learn more
Average: 0

 

Last updated: September 14, 2015